Company news

Avecho Biotechnology Limited news in 2023

Avecho Biotechnology Limited's news releases, calls and decks from 2023, newest first.

View company

September 2023 Quarterly Activities Report & Appendix 4C

October 30, 2023

Reinstatement to Official Quotation

August 28, 2023

Avecho raises further $6M for Phase III trial

August 28, 2023

Voluntary Suspension

August 24, 2023

June 2023 Quarterly Activities Report & Appendix 4C

July 24, 2023

AVE CBD capsule passes two-year stability milestone

June 21, 2023

AVE adds TPM cannabinoid gummies to portfolio

June 6, 2023

USPTO allows new TPM manufacturing patent

May 28, 2023

Avecho licenses TPM for use in cancer drugs

May 22, 2023

AVE commences manufacturing for Phase III trial

May 16, 2023

Results of Entitlement Offer

May 8, 2023

March 2023 Quarterly Activities Report & Appendix 4C

April 27, 2023

Investor Presentation

April 3, 2023

Prospectus

April 3, 2023

Entitlement Offer to raise $11m for Phase 3 clinical trial

April 3, 2023

Clinical CBD program expands with the Lambert Initiative

February 21, 2023

December 2022 Quarterly Activities Report & Appendix 4C

January 30, 2023

Athenex submits Avechos phytonadione to FDA pre-IND

January 12, 2023

Decks in 2023